Microbot Medical Inc.
MBOT
$2.41
$0.114.78%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.12% | -11.26% | -41.99% | -9.70% | -7.55% |
| Total Depreciation and Amortization | -61.54% | -56.52% | -14.29% | -46.43% | -25.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 83.04% | -41.28% | -64.35% | -43.49% | -88.47% |
| Change in Net Operating Assets | -159.05% | -388.82% | 388.96% | -2.64% | 220.31% |
| Cash from Operations | -122.24% | -39.22% | -31.48% | -18.76% | 7.14% |
| Capital Expenditure | -257.14% | -- | -125.00% | 7.14% | -240.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -200.40% | -32,027.86% | -209.24% | -1,854.09% | -49.15% |
| Cash from Investing | -202.54% | -32,037.14% | -210.37% | -1,833.80% | -49.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -11.51% | 7,984.68% | 129.12% | 1,060.03% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -11.51% | 7,984.68% | 129.12% | 1,060.03% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -205.65% | 232.07% | -33.23% | 107.80% | 132.04% |